Swiss All Share Index
17.970,97
PKT
-10,34
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.01.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 28.01.21 | DocMorris buy | Jefferies & Company Inc. | |
| 27.01.21 | Givaudan buy | UBS AG | |
| 27.01.21 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 27.01.21 | Swiss Re Outperform | RBC Capital Markets | |
| 27.01.21 | UBS buy | Kepler Cheuvreux | |
| 27.01.21 | UBS buy | Goldman Sachs Group Inc. | |
| 27.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Novartis Neutral | Credit Suisse Group | |
| 27.01.21 | UBS Outperform | Credit Suisse Group | |
| 27.01.21 | UBS Underweight | Barclays Capital | |
| 26.01.21 | Roche buy | Goldman Sachs Group Inc. | |
| 26.01.21 | ams-OSRAM Outperform | Credit Suisse Group | |
| 26.01.21 | ams-OSRAM overweight | JP Morgan Chase & Co. | |
| 26.01.21 | UBS Neutral | UBS AG | |
| 26.01.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis overweight | Morgan Stanley | |
| 26.01.21 | UBS Equal-Weight | Morgan Stanley | |
| 26.01.21 | Novartis Hold | Kepler Cheuvreux | |
| 26.01.21 | UBS buy | Kepler Cheuvreux | |
| 26.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 26.01.21 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 25.01.21 | Roche Reduce | Oddo BHF | |
| 25.01.21 | Novartis Neutral | Oddo BHF | |
| 25.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.01.21 | Swiss Re Neutral | Credit Suisse Group | |
| 22.01.21 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.21 | Holcim overweight | Morgan Stanley | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 22.01.21 | Novartis Underweight | Barclays Capital | |
| 22.01.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 22.01.21 | DocMorris overweight | Barclays Capital | |
| 21.01.21 | DocMorris buy | Baader Bank | |
| 21.01.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Swiss Re Halten | DZ BANK | |
| 21.01.21 | UBS Outperform | Credit Suisse Group |